Attention healthcare startups, we have extended the deadline to apply to our third complimentary educational program.
We are accepting applications until May 9th, 2025!
Swiss HLG, in partnership with Johnson & Johnson & BaseLaunch initiative is designed to help early-stage healthcare companies become partner-ready and position themselves for long-term success.
If this is relevant for your company, you are very welcome to join us. If not, but you know start-ups that could benefit, please share the information with them. To apply companies should complete the form on our website
LIVE WEBINAR - USA & China - how the environment is changing & how this could impact deal-making.
Swiss HLG & Pharmaceutical Licensing Group UK invites you to join us for this timely webinar 27th of March from 14:30 - 16:00 CET/13:30 -15:00 GMT / 9:30 -11:00 am EST
Fast changing times call for agile deal-making strategies. Join us for strategic insights on the future evolution of the US and China pharmaceutical markets and how this could impact deal making.
Howard Chen, Managing Principal and Head of Services at IQVIA China, brings a wealth of experience in management consulting and investment banking, particularly in the healthcare sector. He has been with IQVIA since 2017 and has over 19 years of experience in the industry, including cross-border M&A deals and fundraising for various healthcare players. His insights on the China perspective are highly valued in the industry.
Michael Margolis, Senior Managing Director and Head of Healthcare Investment Banking at Oppenheimer & Co. Inc.., is known for his expertise in healthcare investment banking. He has advised numerous organizations on strategic growth initiatives and has a deep understanding of the US healthcare market. His perspective on the US healthcare landscape is highly regarded. These two live sessions will be followed by a Q&A.
Swiss Healthcare Licensing group is happy to announce the Swiss Healthcare Start- up Partnering Initiative. An educational program for early-stage healthcare companies to help them become partnering ready
This complimentary program is offered in collaboration with Johnson & Johnson and BaseLaunch, and consists of four linked workshops where leading experts will cover essential topics in healthcare business development.
We look forward to hosting you at our Swiss HLG Start-up Initiative workshops.
APPLICATION FOR THE 2025 STARTUP INITIATIVE
Please note that we request a commitment to attend all 4 complimentary workshops and to fund your own travel.
Swiss HLG Conference 2025 - Registration Open!
We would like to invite you to join us for our flagship annual conference which will once again be held at the historic Belle Epoque Grand Hotel Suisse Majestic in the beautiful scenic location of Montreux, Switzerland on 25th - 27th May 2025.
Our conference is recognised for the consistently high quality of presenters and discussions. Fully 70% of respondents in our 2024 delegate survey rated the program, networking and location all as excellent!
We have an Early Bird special you can benefit from - of you register before February the 28th, 2025 then you will obtain as 50% discount on your 2025 Swiss HLG membership fee!
The 2025 conference title is “Shaping your future..... Act now!” Creative dealmaking to optimize portfolio strategy in a fast- changing environment.
Dealmaking is a crucial tool in building a resilient, future-proofed portfolio for your company. Our conference will equip you with the perspectives, learnings and tools to achieve this goal. Our first session will look at key trends to consider in the biopharma environment, including therapeutic, technological, regulatory, payer and geopolitical developments. We then look at essential concepts to follow in building a portfolio and learn from successful practitioners. Finally, we will see how agile dealmaking an essential tool is when handling unexpected events.
Welcome to our new board member Monika Baudler-Klein
It is with great pleasure to announce that Swiss HLG is welcoming our new board memberMonika Baudler-Klein, joining us from our valued long term supporter Roche.
Monika holds a PhD in Biochemistry fromUniversity of Würzburg and has been in the pharmaceutical industry for more than 25 years working in various discovery, development, commercial and licensing roles with a focus on people and project leadership, portfolio management and strategy giving her a true end-to-end perspective on bringing transformative medicines to patients.
Before joining Roche in 2012, she served as Global Head of Pipeline Sourcing and Portfolio Management at Nycomed where she and her team drove an ambitious in-licensing strategy to complement the company’s portfolio. In her time in Roche, Monika initially focused on supporting the growing Neurology pipeline from a portfolio, commercial and in-licensing strategy perspective before taking on the leadership of the late stage Alzheimer’s portfolio as Life Cycle Leader Gantenerumab and Crenezumab.
A catalyst for building trustful relationships with internal and external stakeholders, she recently joined Roche’s Corporate Business Development as Executive Director Global Alliance & Asset Management leveraging her broad experience in skillfully managing partnerships with diverse external groups and organizations.
Monika adds: ¨I am thrilled to be joining the exceptional and highly experienced Swiss HLG Board and I look forward to making an impact on the active Swiss health care community by contributing my broad pharma expertise and by fostering productive partnerships and cross-industry collaboration.”
Check here in Q1 for information and timelines for the 2025 Swiss HLG Startup Initiative program.
Swiss Healthcare Licensing group is happy to announce the Swiss Healthcare Start- up Partnering Initiative which we have successfully run for 2 years. This is an educational program for early-stage healthcare companies to help them become partnering ready.
This complimentary program is offered in collaboration with Johnson & Johnson Innovation and BaseLaunch, and consists of four linked workshops where leading experts will cover essential topics in healthcare business development.
Roger Schibli, Head of Center for Radiopharmaceutical Sciences at PSI Paul Scherrer Institut will share his insights on RLT a vision for the future and what’s next in RLT.
Ivana Galetic, SVP Program Management at ARTBIO will talk about Developing RLTs and the challenges and opportunities.
Jeevan Virk, Radioligand Therapy (RLT) Leadership at Novartis will speak about bringing RLT to patients including capacity, logistics and positioning.
Julia Hepp, VP Partnering & Alliances and Michael Pitzner, General Counsel, Senior Vice President Legal and Business Development, both from Molecular Partners will exchange on partnering for RLTs and the BD Landscape.
Don’t miss the chance to connect with industry professionals during our networking apero afterwards.
The event will take place at the Novartis Pavillon, November 28th from 5:30pm - 9:00pm
Registration begins at 5:30 PM — reserve your spot today!
Swiss HLG, PLCF & Italy HLG invites you to join us for this timely webinar on the 7th November from 14:30 -16:00 CET.
STRATEGIC COMMERCIALIZATION OPTIONS IN EUROPE FOR MID SIZED HEALTHCARE COMPANIES
Ronald Van Zitteren, Principal at AIM will discuss the challenges faced by New Market Entrants in launching their products in Europe and Francois-Xavier CAPELO, VP International, Bioprojet will talk about Bioprojet’s orphan drug launch in Europe.
These two sessions will be followed by a live Q&A moderated by Bruno Delie, General Manager, Luye Pharma EU.
We are delighted to reveal that the IPLS, the umbrella organisation for all PLG/HLG groups across Europe and Canada, is launching a new IPLS Community Platform, to replace the previous IPLS database.
This is a unique resource that will enable Swiss HLG members to reach out to fellow members, as well as members of other IPLS national groups such as the UK PLG. It is a completely private platform with exciting modern functionality, including a newsfeed and discussion forums. Access to the platform is a significant benefit of Swiss HLG membership. Together with the UK PLG, we are pioneers in adopting the new system and other groups will come on board over the summer. The official launch will be at the IPLS conference on September 16-18 in Malaga.
